Certolizumab Biosimilar - Research Grade

Human

TNFA

5mg/ml

Human Fab'-G1-kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P01375

Blue ice

Tumour necrosis factor alpha (TNF-alpha) is a key pro-inflammatory cytokine driving chronic inflammation in numerous autoimmune disease models. This recombinant anti-human TNF-alpha Fab' fragment is an unconjugated, non-therapeutic analog of certolizumab, intended strictly for research use only (RUO). Built to demanding in vivo standards and low in endotoxin, it is manufactured in scalable milligram (mg) to gram (g) quantities for high-throughput and heavy-usage laboratories. It serves as a dependable neutralizing control and active reagent in cytokine assays, in vitro functional screening, and in vivo inflammatory disease models, with consistent lot-to-lot performance.

CDP870,PHA-738144,tumor necrosis factor (TNF) superfamily member 2, TNFSF2, TNF-alpha, TNFA

Detects human TNFA

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.